Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tharimmune Inc (THAR)

Tharimmune Inc (THAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tharimmune Inc 34 Shrewsbury Ave. Suite 1C Red Bank NJ 07701 USA

www.tharimmune.com Employees: 3 P: 732-889-3111

Sector:

Medical

Description:

Tharimmune Inc. is a biotechnology company. It involved in developing a portfolio of therapeutic candidates for rare immune, inflammatory and oncologic diseases. Tharimmune Inc., formerly known as Hillstream BioPharma Inc., is based in BRIDGEWATER, NJ.

Key Statistics

Overview:

Market Capitalization, $K 164,125
Enterprise Value, $K 160,565
Shares Outstanding, K 37,730
Float, K 35,202
% Float 93.30%
Short Interest, K 1,492
Short Float 3.96%
Days to Cover 2.91
Short Volume Ratio 0.68
% of Insider Shareholders 6.70%
% of Institutional Shareholders 1.16%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -12,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,100 K
EBIT, $ -10,340 K
EBITDA, $ -10,340 K

Growth:

1-Year Return 125.93%
3-Year Return -99.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 11/12/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -3.99
EPS Growth vs. Prev Qtr 46.88%
EPS Growth vs. Prev Year 86.12%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 05/28/24

THAR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -588.45%
Return-on-Assets % -264.41%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.76
Book Value/Share 0.81
Interest Coverage -1,219.00
60-Month Beta 1.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar